Loading clinical trials...
Loading clinical trials...
Randomized Placebo Controlled Trial of High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation
Conditions
Interventions
Thiamine
Normal saline
Locations
1
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
October 16, 2017
Primary Completion Date
March 2, 2020
Completion Date
August 10, 2020
Last Updated
October 19, 2021
NCT05436418
NCT07101588
NCT06093867
NCT04146870
NCT07357389
NCT05837039
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions